Migraine, Headache News & Research | Migraine & Headache Treatment

Migraine and Headache

MIGRAINE AND HEADACHE

Feature Article

Latest

FDA Approves Ubrogepant Tablets for Acute Treatment of Migraine

The Food and Drug Administration (FDA) has approved Ubrelvy (ubrogepant tablets; Allergan), the first oral calcitonin gene-related peptide (CGRP) receptor antagonist, for the acute treatment of migraine with or without aura in adults. The approval was supported by two pivotal phase 3, randomized, double-blind, placebo-controlled trials (ACHIEVE I and ACHIEVE II) that evaluated the efficacy,…
Next post in Migraine & Headache